Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| LILLY ELI & CO | 10% Owner | 1 | $0 | $0 | 2017-03-01 |
| Skwierczynski Raymond | Head,Pharmaceutical Operations | 14 | $0 | $34.4K | 2017-03-01 |
| Mathers Thomas P. | Chief Executive Officer | 49 | $53.3K | $528.2K | 2017-03-01 |
| Kuca Bernice | VP-Clin. and Reg. Operations | 9 | $0 | $55.2K | 2017-03-01 |
| Hogan Linda C. | VP-Business Development | 58 | $0 | $1.33M | 2017-03-01 |
| Marengere Luc | Director, 10% Owner | 10 | $0 | $0 | 2017-03-01 |
| Dallas Matthew D | Chief Financial Officer | 11 | $0 | $105.2K | 2017-03-01 |
| Lawton Alison Frances | Director | 6 | $0 | $0 | 2017-03-01 |
| White Marvin L | Director | 10 | $0 | $0 | 2017-03-01 |
| PAPPAS CAPITAL, LLC | 10% Owner | 5 | $0 | $0 | 2017-03-01 |
| CORRIGAN MARK | Director | 4 | $0 | $0 | 2017-03-01 |
| Novo A/S | 10% Owner | 4 | $15.00M | $0 | 2016-09-09 |
| Domain Partners VI, L.P. | 10% Owner | 1 | $0 | $0 | 2016-09-09 |
| DOVEY BRIAN H | 10% Owner | 11 | $0 | $1.30M | 2016-08-03 |
| PAPPAS ARTHUR M | Director, 10% Owner | 1 | $0 | $0 | 2016-05-10 |
| VITULLO NICOLE | 10% Owner | 1 | $0 | $1.04M | 2016-04-28 |
| Rupniak Nadia | VP-Research and Development | 9 | $0 | $0 | 2015-05-13 |
| TVM Life Science Ventures VII L.P. | 10% Owner | 5 | $5.00M | $0 | 2015-05-11 |
| Care Capital Offshore Investments III LP | 10% Owner | 6 | $0 | $0 | 2015-05-11 |
| A.M. Pappas Life Science Ventures III, L.P. | 10% Owner | 19 | $3.00M | $0 | 2015-05-11 |
| TREU JESSE I | Director, 10% Owner | 9 | $3.90M | $0 | 2015-05-11 |
| Care Capital III LLC | 10% Owner | 5 | $0 | $0 | 2015-05-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| CORRIGAN MARK | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| CORRIGAN MARK | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,114 | $42.71 | $346.5K | 0 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 180,254 | $36.50 | $6.58M | 0 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 30,000 | $38.94 | $1.17M | 0 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 37,500 | $39.75 | $1.49M | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | D To issuer deriv | 2017-03-01 | 2017-03-01 | 5,741 | $38.94 | $223.6K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | D To issuer deriv | 2017-03-01 | 2017-03-01 | 26,594 | $39.75 | $1.06M | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | D To issuer deriv | 2017-03-01 | 2017-03-01 | 46,966 | $36.50 | $1.71M | 0 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | D To issuer deriv | 2017-03-01 | 2017-03-01 | 37,500 | $39.75 | $1.49M | 0 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | D To issuer deriv | 2017-03-01 | 2017-03-01 | 270,381 | $36.50 | $9.87M | 0 | SEC↗ |
| Lawton Alison Frances | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 1,420 | $39.96 | $56.7K | 0 | SEC↗ |
| Lawton Alison Frances | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 658 | $10.30 | $6.8K | 0 | SEC↗ |
| Lawton Alison Frances | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 5,954 | $36.50 | $217.3K | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 1,449 | $38.00 | $55.1K | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 2,371 | $36.88 | $87.4K | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 658 | $10.30 | $6.8K | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 105,147 | $46.50 | $4.89M | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 360,508 | $36.50 | $13.16M | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | D To issuer deriv | 2017-03-01 | 2017-03-01 | 83,000 | $39.75 | $3.30M | 0 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | D To issuer deriv | 2017-03-01 | 2017-03-01 | 90,000 | $40.81 | $3.67M | 0 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | D To issuer deriv | 2017-03-01 | 2017-03-01 | 15,000 | $39.75 | $596.3K | 0 | SEC↗ |
| White Marvin L | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 6,577 | $37.90 | $249.3K | 0 | SEC↗ |
| White Marvin L | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 997 | $38.00 | $37.9K | 0 | SEC↗ |
| White Marvin L | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| White Marvin L | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 1,630 | $36.88 | $60.1K | 0 | SEC↗ |
| White Marvin L | Director | D To issuer deriv | 2017-03-01 | 2017-03-01 | 453 | $10.30 | $4.7K | 0 | SEC↗ |
| PAPPAS CAPITAL, LLC | 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| PAPPAS CAPITAL, LLC | 10% Owner | D To issuer deriv | 2017-03-01 | 2017-03-01 | 5,954 | $36.50 | $217.3K | 0 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | U Tender | 2017-03-01 | 2017-03-01 | 2,708 | $46.50 | $125.9K | 0 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | D To issuer | 2017-03-01 | 2017-03-01 | 37,500 | $46.50 | $1.74M | 0 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | U Tender | 2017-03-01 | 2017-03-01 | 2,729 | $46.50 | $126.9K | 0 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | D To issuer | 2017-03-01 | 2017-03-01 | 37,500 | $46.50 | $1.74M | 0 | SEC↗ |
| Marengere Luc | Director, 10% Owner | U Tender | 2017-03-01 | 2017-03-01 | 1,545,386 | $46.50 | $71.86M | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | D To issuer | 2017-03-01 | 2017-03-01 | 83,000 | $46.50 | $3.86M | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | U Tender | 2017-03-01 | 2017-03-01 | 173,519 | $46.50 | $8.07M | 0 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | U Tender | 2017-03-01 | 2017-03-01 | 3,615 | $46.50 | $168.1K | 0 | SEC↗ |
| PAPPAS CAPITAL, LLC | 10% Owner | U Tender | 2017-03-01 | 2017-03-01 | 1,871,049 | $46.50 | $87.00M | 0 | SEC↗ |
| PAPPAS CAPITAL, LLC | 10% Owner | U Tender | 2017-03-01 | 2017-03-01 | 116,317 | $46.50 | $5.41M | 0 | SEC↗ |
| PAPPAS CAPITAL, LLC | 10% Owner | U Tender | 2017-03-01 | 2017-03-01 | 5,528 | $46.50 | $257.1K | 0 | SEC↗ |
| LILLY ELI & CO | 10% Owner | J Other | 2017-03-01 | 2017-03-01 | 19,285,108 | $46.50 | $896.76M | 100 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2017-01-05 | 2017-01-05 | 1,677 | — | $0 | 46,966 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2017-01-05 | 2017-01-05 | 3,755 | — | $0 | 105,147 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2017-01-05 | 2017-01-05 | 1,677 | $10.00 | $16.8K | 1,677 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2017-01-05 | 2017-01-05 | 477 | $33.55 | $16.0K | 1,200 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2017-01-05 | 2017-01-05 | 600 | $34.40 | $20.6K | 600 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2017-01-05 | 2017-01-05 | 600 | $35.61 | $21.4K | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2017-01-05 | 2017-01-05 | 200 | $34.86 | $7.0K | 257,019 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2017-01-05 | 2017-01-05 | 3,755 | — | $0 | 258,021 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2017-01-05 | 2017-01-05 | 500 | $35.60 | $17.8K | 256,519 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2017-01-05 | 2017-01-05 | 802 | $34.25 | $27.5K | 257,219 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2017-01-04 | 2017-01-05 | 185 | — | $0 | 5,741 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2017-01-04 | 2017-01-05 | 185 | $36.40 | $6.7K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2017-01-04 | 2017-01-05 | 185 | $7.56 | $1.4K | 185 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2017-01-03 | 2017-01-04 | 658 | $30.40 | $20.0K | 658 | SEC↗ |
| Marengere Luc | Director, 10% Owner | A Award deriv | 2017-01-03 | 2017-01-04 | 658 | $30.40 | $20.0K | 658 | SEC↗ |
| White Marvin L | Director | A Award deriv | 2017-01-03 | 2017-01-04 | 453 | $30.35 | $13.7K | 453 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2017-01-03 | 2017-01-05 | 718 | — | $0 | 26,594 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | S Sale | 2017-01-03 | 2017-01-04 | 1,473 | $36.25 | $53.4K | 40,128 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | S Sale | 2017-01-03 | 2017-01-04 | 772 | $36.25 | $28.0K | 40,086 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2017-01-03 | 2017-01-05 | 718 | $36.25 | $26.0K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2017-01-03 | 2017-01-05 | 718 | $6.75 | $4.8K | 718 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-12-05 | 2016-12-05 | 186 | — | $0 | 5,926 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-12-05 | 2016-12-05 | 1,678 | — | $0 | 48,643 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-12-05 | 2016-12-05 | 3,756 | — | $0 | 108,902 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-12-05 | 2016-12-05 | 1,678 | $38.75 | $65.0K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-12-05 | 2016-12-05 | 1,678 | $10.00 | $16.8K | 1,678 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-12-05 | 2016-12-05 | 186 | $7.56 | $1.4K | 186 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-12-05 | 2016-12-05 | 186 | $38.75 | $7.2K | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-12-05 | 2016-12-05 | 3,756 | — | $0 | 255,768 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-12-05 | 2016-12-05 | 1,502 | $38.75 | $58.2K | 254,266 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-12-01 | 2016-12-05 | 719 | — | $0 | 27,312 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | S Sale | 2016-12-01 | 2016-12-01 | 1,473 | $35.17 | $51.8K | 41,601 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | S Sale | 2016-12-01 | 2016-12-01 | 772 | $35.22 | $27.2K | 40,858 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-12-01 | 2016-12-05 | 719 | $6.75 | $4.9K | 719 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-12-01 | 2016-12-05 | 719 | $35.22 | $25.3K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-11-07 | 2016-11-07 | 1,677 | — | $0 | 50,321 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-11-07 | 2016-11-07 | 1,677 | $10.00 | $16.8K | 1,677 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-11-07 | 2016-11-07 | 1,677 | $28.52 | $47.8K | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-11-07 | 2016-11-07 | 1,502 | $28.57 | $42.9K | 248,920 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-11-05 | 2016-11-07 | 3,755 | — | $0 | 112,658 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-11-05 | 2016-11-07 | 3,755 | — | $0 | 250,422 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-11-04 | 2016-11-07 | 185 | — | $0 | 6,112 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-11-04 | 2016-11-07 | 185 | $28.95 | $5.4K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-11-04 | 2016-11-07 | 185 | $7.56 | $1.4K | 185 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-11-01 | 2016-11-01 | 719 | — | $0 | 28,031 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-11-01 | 2016-11-01 | 719 | $6.75 | $4.9K | 719 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-11-01 | 2016-11-01 | 719 | $30.00 | $21.6K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-10-05 | 2016-10-05 | 1,677 | — | $0 | 51,998 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-10-05 | 2016-10-05 | 3,755 | — | $0 | 116,413 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-10-05 | 2016-10-05 | 1,677 | $37.08 | $62.2K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-10-05 | 2016-10-05 | 1,677 | $10.00 | $16.8K | 1,677 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-10-05 | 2016-10-05 | 3,755 | — | $0 | 248,169 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-10-05 | 2016-10-05 | 1,502 | $37.08 | $55.7K | 246,667 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-10-04 | 2016-10-05 | 185 | — | $0 | 6,297 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-10-04 | 2016-10-05 | 185 | $7.56 | $1.4K | 185 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-10-04 | 2016-10-05 | 185 | $36.41 | $6.7K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-10-03 | 2016-10-05 | 719 | — | $0 | 28,750 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-10-03 | 2016-10-05 | 719 | $37.74 | $27.1K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-10-03 | 2016-10-05 | 719 | $6.75 | $4.9K | 719 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-14 | 2016-09-16 | 300 | $23.78 | $7.1K | 244,414 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-14 | 2016-09-16 | 5,700 | $23.30 | $132.8K | 244,714 | SEC↗ |
| Novo A/S | 10% Owner | P Buy | 2016-09-09 | 2016-09-13 | 100,000 | $20.00 | $2.00M | 3,156,563 | SEC↗ |
| Domain Partners VI, L.P. | 10% Owner | J Other | 2016-09-09 | 2016-09-13 | 1,943,109 | — | $0 | 0 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-07 | 2016-09-07 | 962 | $21.90 | $21.1K | 253,789 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-07 | 2016-09-07 | 663 | $20.56 | $13.6K | 254,751 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-07 | 2016-09-07 | 2,633 | $22.62 | $59.6K | 251,156 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-07 | 2016-09-07 | 300 | $24.40 | $7.3K | 250,414 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-07 | 2016-09-07 | 442 | $23.43 | $10.4K | 250,714 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-09-06 | 2016-09-07 | 896 | — | $0 | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-09-06 | 2016-09-07 | 36,452 | — | $0 | 53,675 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-09-06 | 2016-09-07 | 3,518 | — | $0 | 6,482 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-09-06 | 2016-09-07 | 2,839 | — | $0 | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise deriv | 2016-09-06 | 2016-09-07 | 5,031 | — | $0 | 29,469 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-09-06 | 2016-09-07 | 1,502 | $19.50 | $29.3K | 255,414 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-09-06 | 2016-09-07 | 31,420 | $20.00 | $628.4K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-09-06 | 2016-09-07 | 5,032 | $20.00 | $100.6K | 31,420 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-09-06 | 2016-09-07 | 3,518 | $7.56 | $26.6K | 39,970 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-09-06 | 2016-09-07 | 5,031 | $6.75 | $34.0K | 45,001 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-09-06 | 2016-09-07 | 2,839 | $5.09 | $14.5K | 2,839 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-09-06 | 2016-09-07 | 896 | $5.09 | $4.6K | 3,735 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-09-06 | 2016-09-07 | 3,735 | $19.50 | $72.8K | 0 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | M Exercise | 2016-09-06 | 2016-09-07 | 36,452 | $10.00 | $364.5K | 36,452 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | S Sale | 2016-09-06 | 2016-09-07 | 8,549 | $19.50 | $166.7K | 36,452 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-09-05 | 2016-09-07 | 3,756 | — | $0 | 120,168 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-09-05 | 2016-09-07 | 3,756 | — | $0 | 256,916 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-08-31 | 2016-08-31 | 150 | $10.86 | $1.6K | 47 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-08-19 | 2016-08-19 | 508 | $8.41 | $4.3K | 197 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-08-10 | 2016-08-10 | 508 | $8.30 | $4.2K | 705 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-08-05 | 2016-08-05 | 3,755 | — | $0 | 123,924 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-08-05 | 2016-08-05 | 3,755 | — | $0 | 254,662 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-08-05 | 2016-08-05 | 1,502 | $8.31 | $12.5K | 253,160 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-03 | 2016-08-03 | 81,094 | $8.15 | $660.9K | 1,943,109 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-03 | 2016-08-03 | 129 | $8.15 | $1.1K | 3,039 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-02 | 2016-08-03 | 19,718 | $8.71 | $171.7K | 2,024,203 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-02 | 2016-08-03 | 32 | $8.71 | $279 | 3,168 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-01 | 2016-08-03 | 52,216 | $8.82 | $460.5K | 2,043,921 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-08-01 | 2016-08-03 | 84 | $8.82 | $741 | 3,200 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-07-29 | 2016-07-29 | 508 | $9.09 | $4.6K | 1,213 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-07-20 | 2016-07-20 | 508 | $8.97 | $4.6K | 1,721 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-07-11 | 2016-07-12 | 508 | $9.10 | $4.6K | 2,229 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-07-05 | 2016-07-05 | 3,755 | — | $0 | 127,679 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-07-05 | 2016-07-05 | 1,502 | $9.73 | $14.6K | 250,907 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-07-05 | 2016-07-05 | 3,755 | — | $0 | 252,409 | SEC↗ |
| Marengere Luc | Director, 10% Owner | A Award deriv | 2016-07-01 | 2016-07-05 | 2,371 | $8.44 | $20.0K | 2,371 | SEC↗ |
| White Marvin L | Director | A Award deriv | 2016-07-01 | 2016-07-05 | 1,630 | $8.44 | $13.8K | 1,630 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-06-30 | 2016-06-30 | 516 | $7.01 | $3.6K | 2,737 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-06-20 | 2016-06-22 | 500 | $7.00 | $3.5K | 3,253 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | S Sale | 2016-06-10 | 2016-06-22 | 508 | $6.60 | $3.4K | 3,753 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | S Sale | 2016-06-06 | 2016-06-07 | 1,502 | $7.25 | $10.9K | 248,654 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-06-05 | 2016-06-07 | 3,756 | — | $0 | 131,434 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-06-05 | 2016-06-07 | 3,756 | — | $0 | 250,156 | SEC↗ |
| CORRIGAN MARK | Director | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| Marengere Luc | Director, 10% Owner | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| PAPPAS ARTHUR M | Director, 10% Owner | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| White Marvin L | Director | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2016-05-05 | 2016-05-09 | 45,064 | — | $0 | 135,190 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2016-05-05 | 2016-05-09 | 45,064 | — | $0 | 256,024 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | F Tax w/h | 2016-05-05 | 2016-05-09 | 14,624 | $6.49 | $94.9K | 241,400 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | S Sale | 2016-04-28 | 2016-05-02 | 235 | $6.96 | $1.6K | 3,284 | SEC↗ |
| VITULLO NICOLE | 10% Owner | S Sale | 2016-04-28 | 2016-05-02 | 149,765 | $6.96 | $1.04M | 2,096,137 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2016-03-11 | 2016-03-15 | 1,420 | — | $0 | 1,420 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | A Award deriv | 2016-03-04 | 2016-03-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Hogan Linda C. | Head, Bus. Dev. and Strategy | A Award deriv | 2016-03-04 | 2016-03-07 | 34,500 | — | $0 | 34,500 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | A Award deriv | 2016-03-04 | 2016-03-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | A Award deriv | 2016-03-04 | 2016-03-07 | 83,000 | — | $0 | 83,000 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | A Award deriv | 2016-03-04 | 2016-03-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | A Award | 2016-03-04 | 2016-03-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Kuca Bernice | Head,Clin. and Reg. Operatio | A Award | 2016-03-04 | 2016-03-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | A Award | 2016-03-04 | 2016-03-07 | 83,000 | — | $0 | 210,960 | SEC↗ |
| Marengere Luc | Director, 10% Owner | A Award deriv | 2016-01-04 | 2016-01-06 | 1,449 | $6.90 | $10.0K | 1,449 | SEC↗ |
| White Marvin L | Director | A Award deriv | 2016-01-04 | 2016-01-06 | 997 | $6.90 | $6.9K | 997 | SEC↗ |
| Skwierczynski Raymond | Head,Pharmaceutical Operatio | A Award deriv | 2015-11-30 | 2015-12-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise deriv | 2015-11-05 | 2015-11-06 | 180,254 | — | $0 | 180,254 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | M Exercise | 2015-11-05 | 2015-11-06 | 180,254 | — | $0 | 187,754 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | F Tax w/h | 2015-11-05 | 2015-11-06 | 59,794 | $4.58 | $273.9K | 127,960 | SEC↗ |
| CORRIGAN MARK | Director | A Award deriv | 2015-10-27 | 2015-10-29 | 8,114 | — | $0 | 8,114 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | P Buy | 2015-08-25 | 2015-08-25 | 7,500 | $7.10 | $53.3K | 7,500 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | A Award deriv | 2015-08-04 | 2015-08-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Hogan Linda C. | VP-Business Development | A Award deriv | 2015-08-04 | 2015-08-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| White Marvin L | Director | A Award deriv | 2015-07-09 | 2015-07-13 | 6,577 | — | $0 | 6,577 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise deriv | 2015-05-13 | 2015-05-13 | 2,457 | — | $0 | 0 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise deriv | 2015-05-13 | 2015-05-13 | 3,690 | — | $0 | 0 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise deriv | 2015-05-13 | 2015-05-13 | 5,541 | — | $0 | 0 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise deriv | 2015-05-13 | 2015-05-13 | 2,457 | — | $0 | 0 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise | 2015-05-13 | 2015-05-13 | 2,457 | $4.07 | $10.0K | 4,914 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise | 2015-05-13 | 2015-05-13 | 2,457 | $4.07 | $10.0K | 2,457 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise | 2015-05-13 | 2015-05-13 | 5,541 | $5.09 | $28.2K | 10,455 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | M Exercise | 2015-05-13 | 2015-05-13 | 3,690 | $5.09 | $18.8K | 14,145 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-11 | 464,756 | — | $0 | 0 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-11 | 939,289 | — | $0 | 0 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-11 | 798,188 | — | $0 | 0 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,954 | — | $0 | 0 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,565 | — | $0 | 0 | SEC↗ |
| TVM Life Science Ventures VII | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 995,386 | — | $0 | 0 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 20,050 | — | $0 | 0 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 1,199,841 | — | $0 | 0 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 320,295 | — | $0 | 0 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 5,353 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 35,953 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 578,297 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 20,808 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 334,722 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 675,588 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 41,996 | — | $0 | 0 | SEC↗ |
| Novo A/S | 10% Owner | C Conversion deriv | 2015-05-11 | 2015-05-12 | 1,756,563 | — | $0 | 0 | SEC↗ |
| DOVEY BRIAN H | 10% Owner | C Conversion | 2015-05-11 | 2015-05-11 | 2,202,233 | — | $0 | 2,245,902 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | C Conversion | 2015-05-11 | 2015-05-11 | 3,519 | — | $0 | 3,519 | SEC↗ |
| TVM Life Science Ventures VII | 10% Owner | P Buy | 2015-05-11 | 2015-05-12 | 500,000 | $10.00 | $5.00M | 1,495,386 | SEC↗ |
| TVM Life Science Ventures VII | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 995,386 | — | $0 | 995,386 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 1,520,136 | — | $0 | 1,520,136 | SEC↗ |
| Care Capital Offshore Investme | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 25,403 | — | $0 | 25,403 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 1,588,607 | — | $0 | 1,588,609 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy | 2015-05-11 | 2015-05-12 | 17,560 | $10.00 | $175.6K | 116,317 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 98,757 | — | $0 | 98,757 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy | 2015-05-11 | 2015-05-12 | 282,440 | $10.00 | $2.82M | 1,871,049 | SEC↗ |
| Novo A/S | 10% Owner | P Buy | 2015-05-11 | 2015-05-12 | 1,300,000 | $10.00 | $13.00M | 3,056,563 | SEC↗ |
| Novo A/S | 10% Owner | C Conversion | 2015-05-11 | 2015-05-12 | 1,756,563 | — | $0 | 1,756,563 | SEC↗ |
| Dallas Matthew D | Chief Financial Officer | A Award deriv | 2015-05-05 | 2015-05-07 | 180,254 | — | $0 | 180,254 | SEC↗ |
| Hogan Linda C. | VP-Business Development | A Award deriv | 2015-05-05 | 2015-05-07 | 90,127 | — | $0 | 90,127 | SEC↗ |
| Kuca Bernice | VP-Clin. and Reg. Operations | A Award deriv | 2015-05-05 | 2015-05-07 | 270,381 | — | $0 | 270,381 | SEC↗ |
| TVM Life Science Ventures VII | 10% Owner | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| Care Capital III LLC | 10% Owner | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | A Award deriv | 2015-05-05 | 2015-05-07 | 360,508 | — | $0 | 360,508 | SEC↗ |
| Mathers Thomas P. | Chief Executive Officer | A Award deriv | 2015-05-05 | 2015-05-07 | 360,508 | — | $0 | 360,508 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| Rupniak Nadia | VP-Research and Development | A Award deriv | 2015-05-05 | 2015-05-07 | 135,190 | — | $0 | 135,190 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | A Award deriv | 2015-05-05 | 2015-05-11 | 5,954 | — | $0 | 5,954 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | M Exercise deriv | 2015-03-23 | 2015-05-07 | 5,528 | — | $0 | 0 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | M Exercise | 2015-03-23 | 2015-05-07 | 5,528 | $4.07 | $22.5K | 5,528 | SEC↗ |
| TVM Life Science Ventures VII | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 995,386 | — | $0 | 995,386 | SEC↗ |
| Care Capital III LLC | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 320,295 | — | $0 | 320,295 | SEC↗ |
| Care Capital III LLC | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 16,041 | — | $0 | 16,041 | SEC↗ |
| Care Capital III LLC | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 5,353 | — | $0 | 5,353 | SEC↗ |
| Care Capital III LLC | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 959,872 | — | $0 | 959,872 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 20,808 | — | $0 | 20,808 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 334,722 | — | $0 | 334,722 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 33,597 | — | $0 | 33,597 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 540,470 | — | $0 | 540,470 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 28,763 | — | $0 | 28,763 | SEC↗ |
| A.M. Pappas Life Science Ventu | 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-07 | 462,637 | — | $0 | 462,637 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | J Other deriv | 2015-01-12 | 2015-05-11 | 752,684 | — | $0 | 939,289 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | J Other deriv | 2015-01-12 | 2015-05-11 | 640,114 | — | $0 | 798,188 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | P Buy deriv | 2015-01-12 | 2015-05-11 | 456,301 | $8.54 | $3.90M | 464,756 | SEC↗ |
| TREU JESSE I | Director, 10% Owner | J Other deriv | 2014-12-15 | 2015-05-11 | 8,455 | $8.54 | $72.2K | 8,455 | SEC↗ |